Lamia Tazi Gains 14 Million From Sothema Stake In 18 Days

Tazis stake has surged by MAD138.57 million 14.93 million over just 18 days, as the companys stock surged on the Casablanca Bourse.

Sothemas share price jumped 23.62 percent from MAD995 107.17 on April 7 to MAD1,230 132.486, pushing the companys market capitalization close to 970 million.

With a 29.95-percent year-to-date gain, Sothema stands among the top-performing stocks on the Casablanca Bourse.

Lamia Tazi, a prominent figure in Moroccos pharmaceutical sector, has seen a significant surge in the market value of her stake in Marocaine Ste de Therapeutique Sothema, bringing his stake closer to 80 million. This upswing has further cemented her position among Moroccos wealthiest individuals.

As CEO and Chairwoman of Sothema, Tazi holds an 8.19-percent stake in the company, representing 589,658 shares. Over the past 18 days, the companys stock on the Casablanca Bourse has climbed sharply, increasing the value of her holdings by MAD138.57 million 14.93 million.

This builds on an earlier gain of 8 million between Jan. 1 and Mar. 4 , when the value of her stake rose from MAD545.43 million 54.9 million to MAD625.04 million 62.91 million. The rise in Sothemas shares points to growing investor confidence, not just in the companys future, but in Tazis leadership.

Sothema , Moroccos healthcare company, produces about 60 million pharmaceutical units each year and partners with 35 multinational laboratories. Its products are distributed across Europe, the Maghreb, Sub-Saharan Africa, and the Persian Gulf, reflecting its key role in the regions healthcare supply chain.

Over the past 18 days, Sothemas stock has surged by 23.62 percent on the Casablanca Bourse, driving its market capitalization close to 970 million. The share price climbed from MAD995 107.17 on April 7 to MAD1,230 132.486 at the time of reporting, delivering robust returns for investors.